Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 48 for prostate cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. FDA approved Computer-assisted Trans-perineal/Trans-rectal Prostate Biopsy Devices With and Without MRI U/S Fusion

    Rochester, MN

  2. A Study of Vesicles, Prostate Cancer

    Rochester, MN

  3. A Study To Evaluate The Impact On Metastases-free Survival With The Addition Of Saruparib Versus Placebo To A Standard Radiotherapy/androgen Deprivation Regimen In Men With High-risk Prostate Cancer With A BRCA Mutation.

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Clinical Study Of Ifinatamab Deruxtecan (I-DXd) In People With Metastatic Prostate Cancer (MK-2400-001)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Positron Emission Tomography Using 64Cu-SAR-bisPSMA In Participants With High-risk Prostate Cancer Prior To Radical Prostatectomy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Androgen Deprivation To Enrich PSMA Expression And Improve Sensitivity Of Staging PSMA PET/C

    Scottsdale/Phoenix, AZ

  8. Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy In Black Men With Locally Advanced, Biochemically Recurrent And Metastatic Prostate Cancer

    Jacksonville, FL

  9. Risk Stratified De-escalated De-intensified Treatment for High Risk Prostate Cancer

    Scottsdale/Phoenix, AZ

  10. Comparison of standard care with radiation and medicinal therapy vs radiation alone for prostate cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer